Literature DB >> 3276232

Hemolytic-uremic syndrome: a population-based study in Washington, DC and Baltimore, Maryland.

J S Kinney1, T P Gross, C C Porter, M F Rogers, L B Schonberger, E S Hurwitz.   

Abstract

A population-based study of hemolytic-uremic syndrome (HUS) revealed that 20 child residents of Washington, DC and Baltimore, Maryland were hospitalized with HUS from January 1979 through September 1983. The number of cases peaked during the summer and fall; none occurred during the winter. Incidence of hospitalized cases was higher in Whites and girls than in Blacks or boys, and the average annual incidence was 1.08 cases/100,000 children less than 5 year old. This study demonstrates that HUS is not unique to the West Coast, as previously suggested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276232      PMCID: PMC1349211          DOI: 10.2105/ajph.78.1.64

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  19 in total

1.  Enteroviruses associated with the hemolytic-uremic syndrome.

Authors:  C G Ray; V L Tucker; D J Harris; F E Cuppage; T D Chin
Journal:  Pediatrics       Date:  1970-09       Impact factor: 7.124

2.  Coxsackie virus group B infections and the hemolytic-uremic syndrome.

Authors:  T W Austin; C G Ray
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

3.  The hemolytic-uremic syndrome in California: a review of 28 nonheparinized cases with long-term follow-up.

Authors:  B M Tune; T J Leavitt; T J Gribble
Journal:  J Pediatr       Date:  1973-02       Impact factor: 4.406

Review 4.  The hemolytic uremic syndrome.

Authors:  B S Kaplan; P D Thomson; J P de Chadarévian
Journal:  Pediatr Clin North Am       Date:  1976-11       Impact factor: 3.278

5.  The hemolytic-uremic syndrome: experience at a center in the Midwest.

Authors:  L Y Sorrenti; P R Lewy
Journal:  Am J Dis Child       Date:  1978-01

6.  The hemolytic-uremic syndrome: spectrum of severity and significance of prodrome.

Authors:  D Dolislager; B Tune
Journal:  Am J Dis Child       Date:  1978-01

7.  Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center.

Authors:  J S Spika; J E Parsons; D Nordenberg; J G Wells; R A Gunn; P A Blake
Journal:  J Pediatr       Date:  1986-08       Impact factor: 4.406

8.  A population-based study of hemolytic-uremic syndrome in Oregon, 1979-1982.

Authors:  M F Rogers; G W Rutherford; S R Alexander; J H DiLiberti; L Foster; L B Schonberger; E S Hurwitz
Journal:  Am J Epidemiol       Date:  1986-01       Impact factor: 4.897

9.  Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest.

Authors:  M A Neill; P I Tarr; C R Clausen; D L Christie; R O Hickman
Journal:  Pediatrics       Date:  1987-07       Impact factor: 7.124

10.  Hemolytic uremic syndrome epidemiology: a population-based study in King County, Washington, 1971 to 1980.

Authors:  P I Tarr; R O Hickman
Journal:  Pediatrics       Date:  1987-07       Impact factor: 7.124

View more
  9 in total

Review 1.  Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.

Authors:  B E Mahon; P M Griffin; P S Mead; R V Tauxe
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

2.  Haemolytic anaemia after childhood Escherichia coli O 157 .H7 infection: are females at increased risk?

Authors:  P C Rowe; W Walop; H Lior; A M Mackenzie
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

Review 3.  Contemporary issues: diseases with a food vector.

Authors:  D L Archer; F E Young
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

4.  Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.

Authors:  D V Milford; C M Taylor; B Guttridge; S M Hall; B Rowe; H Kleanthous
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

5.  Haemolytic uraemic syndrome in the defined population of northeast of Scotland.

Authors:  I A Abu-Arafeh; P J Smail; G G Youngson; I A Auchterlonie
Journal:  Eur J Pediatr       Date:  1991-02       Impact factor: 3.183

6.  Haemolytic uraemic syndrome in children admitted to a rural district hospital in Kenya.

Authors:  Ally Ibrahim Olotu; S Mithwani; C R J C Newton
Journal:  Trop Doct       Date:  2008-07       Impact factor: 0.731

Review 7.  Racial incidence of hemolytic uremic syndrome.

Authors:  S M Jernigan; F B Waldo
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

Review 8.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

9.  Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study.

Authors:  Natalie Adams; Lisa Byrne; Tanith Rose; Bob Adak; Claire Jenkins; Andre Charlett; Mara Violato; Sarah O'Brien; Margaret Whitehead; Benjamin Barr; David Taylor-Robinson; Jeremy Hawker
Journal:  BMJ Paediatr Open       Date:  2019-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.